Clinical Trial Update: Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dupilumab in pediatric patients with atopic dermatitis in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED